We are building a new class of biology—programmable, scalable, and precise. Our multi-agent AI platform harnesses biomimetic principles to engineer two breakthroughs: synthetic cell therapies for regenerative medicine and adaptive biomimetic membranes for targeted bioactive delivery across therapeutic indications and industries.
Our first use case is Osteoarthritis.
A full therapeutic replacement — scalable, stable, and cell-free. https://www.stemtology.com/
You’ll Work On:
- Culturing chondrocytes (2D + 3D Osteoarthritis models)
- Running core assays: qPCR, ELISA, flow cytometry, fluorescent microscopy, etc.
- Building and validating platform in-vitro models in conjunction with our in-silico platform
- Data analysis, literature reviews, and assistance with creating scientific decks
- Working with CROs for in-vivo studies
You:
- Must have 4+ years with mammalian cell culture (industry or academic)
- Must have 2+ years of R&D side industry experience (CRO/preclinical discovery heavily preferred) OR 2+ years experience at cartilage, tissue engineering, inflammatory disease, or cancer biology academic lab
- Must have deep familiarity with OA, chondrocytes, cartilage regeneration, or cytokine biology
- Must have extensive hands-on with ELISA, qPCR, and other cell-based assays
- Bonus: Experience with recombinant proteins, bioreactors, MSCs, or synthetic biology
- Bonus: ML and computational experience
- Bold scientific vision and ambitions to shape and commercialize novel technology
How We Hire:
As one of the initial team members of an early-stage, high-growth biotech startup, you will have an excellent opportunity for personal growth as the company expands and your ideas will be critical for developing the company culture and policies. This is a rare opportunity to work alongside the founding team and grow into a CTO position early-career.
Part-time first (3 months) — real work, real results.
Mutual fit → Full-time role with significant equity.
Ownership from Day 1.
Competitive compensation commensurate with experience, in the $30-$45 per hour base rate.
Tax-free on income tax as part of Startup NY program
Flexible remote option when no on-site lab work is performed
Top Skills
What We Do
We are building a synthetic alternative to cell therapies—a tunable, cell-free system that mimics regenerative signaling with precision across indications. Our first candidate targets Osteoarthritis.
